Literature DB >> 11728458

The antimicrobial peptides lactoferricin B and magainin 2 cross over the bacterial cytoplasmic membrane and reside in the cytoplasm.

H H Haukland1, H Ulvatne, K Sandvik, L H Vorland.   

Abstract

The localization of immunolabelled antimicrobial peptides was studied using transmission electron microscopy. Staphylococcus aureus and Escherichia coli were exposed to lactoferricin B (17-41), lactoferricin B (17-31) and D-lactoferricin B (17-31). E. coli was also exposed to cecropin P1 and magainin 2. The lactoferricins were found in the cytoplasm of both bacteria. In S. aureus the amount of cytoplasmic lactoferricin B (17-41) was time- and concentration-dependent, reaching a maximum within 30 min. Cecropin P1 was confined to the cell wall, while magainin 2 was found in the cytoplasm of E. coli. The finding of intracellularly localized magainin is not reported previously.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11728458     DOI: 10.1016/s0014-5793(01)03100-3

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  39 in total

1.  Lactoferricin B inhibits the phosphorylation of the two-component system response regulators BasR and CreB.

Authors:  Yu-Hsuan Ho; Tzu-Cheng Sung; Chien-Sheng Chen
Journal:  Mol Cell Proteomics       Date:  2011-12-02       Impact factor: 5.911

2.  Candidacidal effects of two antimicrobial peptides: histatin 5 causes small membrane defects, but LL-37 causes massive disruption of the cell membrane.

Authors:  Alice L den Hertog; Jan van Marle; Henk A van Veen; Wim Van't Hof; Jan G M Bolscher; Enno C I Veerman; Arie V Nieuw Amerongen
Journal:  Biochem J       Date:  2005-06-01       Impact factor: 3.857

3.  Naturally processed dermcidin-derived peptides do not permeabilize bacterial membranes and kill microorganisms irrespective of their charge.

Authors:  H Steffen; S Rieg; I Wiedemann; H Kalbacher; M Deeg; H-G Sahl; A Peschel; F Götz; C Garbe; B Schittek
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

Review 4.  Peptide antimicrobial agents.

Authors:  Håvard Jenssen; Pamela Hamill; Robert E W Hancock
Journal:  Clin Microbiol Rev       Date:  2006-07       Impact factor: 26.132

5.  Dermcidin-derived peptides show a different mode of action than the cathelicidin LL-37 against Staphylococcus aureus.

Authors:  Ilknur Senyürek; Maren Paulmann; Tobias Sinnberg; Hubert Kalbacher; Martin Deeg; Thomas Gutsmann; Marina Hermes; Thomas Kohler; Fritz Götz; Christiane Wolz; Andreas Peschel; Birgit Schittek
Journal:  Antimicrob Agents Chemother       Date:  2009-04-13       Impact factor: 5.191

Review 6.  Topical antimicrobials for burn infections - an update.

Authors:  Mert Sevgi; Ani Toklu; Daniela Vecchio; Michael R Hamblin
Journal:  Recent Pat Antiinfect Drug Discov       Date:  2013-12

7.  Systematic Analysis of Intracellular-targeting Antimicrobial Peptides, Bactenecin 7, Hybrid of Pleurocidin and Dermaseptin, Proline-Arginine-rich Peptide, and Lactoferricin B, by Using Escherichia coli Proteome Microarrays.

Authors:  Yu-Hsuan Ho; Pramod Shah; Yi-Wen Chen; Chien-Sheng Chen
Journal:  Mol Cell Proteomics       Date:  2016-02-22       Impact factor: 5.911

8.  Rationale-based, de novo design of dehydrophenylalanine-containing antibiotic peptides and systematic modification in sequence for enhanced potency.

Authors:  Sarika Pathak; Virander Singh Chauhan
Journal:  Antimicrob Agents Chemother       Date:  2011-02-14       Impact factor: 5.191

Review 9.  Properties and mechanisms of action of naturally occurring antifungal peptides.

Authors:  Nicole L van der Weerden; Mark R Bleackley; Marilyn A Anderson
Journal:  Cell Mol Life Sci       Date:  2013-02-05       Impact factor: 9.261

10.  Ultrastructural effects and antibiofilm activity of LFchimera against Burkholderia pseudomallei.

Authors:  Aekkalak Puknun; Sakawrat Kanthawong; Chitchanok Anutrakunchai; Kamran Nazmi; Wikky Tigchelaar; Kees A Hoeben; Enno C I Veerman; Jan G M Bolscher; Suwimol Taweechaisupapong
Journal:  World J Microbiol Biotechnol       Date:  2016-01-11       Impact factor: 3.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.